News

The companies will jointly conduct and share the costs of a Phase Ib/II clinical trial seeking to determine whether the combination therapy can improve overall response rate, in

Allergan’s ANDA product is a generic version of United Therapeutics Corporation’s Tyvaso, which is indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability. United

This recall has been initiated as a precautionary measure due to the identification of a Clopidogrel tablet found in a bottle of the product. The risk associated with

This research, conducted at University of California, San Diego, and University of California, Davis, supports the use of dual NOX1&4 inhibitors for the treatment of liver fibrosis, such

Results from the study demonstrated that the trial did not meet its primary endpoint of non-inferiority in overall treatment response in isavuconazole-treated patients at the end of IV

Healthcare providers will now have the option for either a gluteal or deltoid injection site for administering Abilify Maintena to patients with schizophrenia. Abilify Maintena is the first

AL-704 is a nucleotide based NS5B polymerase inhibitor also known as JNJ-54257099, by Alios Biopharma, part of the Janssen Pharmaceutical Companies. It is intended for the treatment of

The IND acceptance allows the company to start an open-label Phase I trial designed to evaluate the safety, pharmacokinetics and clinical activity of KB003 in previously treated CMML

FX006 is a new, non-opioid, sustained-release, intra-articular (IA) (within the joint) formulation of triamcinolone acetonide (TCA) designed to treat patients with moderate to severe osteoarthritis (OA) pain of